EURONA MEDICAL AB has a total of 12 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, foods and drinks and pharmaceuticals are YEASEN BIOLOGICAL TECH SHANGHAI CO LTD, LONGAS TECH PTY LTD and PLANT GENOME CT CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | United Kingdom | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Foods and drinks | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Enzymes | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Karpe Fredrik | 5 |
#2 | Jonsson Lena | 3 |
#3 | Andersson Maria Kristina | 3 |
#4 | Lindstrom Per Harry Rutger | 2 |
#5 | Norberg Leif Torbjorn | 2 |
#6 | Dahl Niklas | 2 |
#7 | Draptchinskaia Natalia | 2 |
#8 | Gustavsson Peter | 2 |
#9 | Norberg Leif Torbjoern | 1 |
#10 | Lindstroem Harry Rutger | 1 |
Publication | Filing date | Title |
---|---|---|
GB0004396D0 | Methods for SNP determination | |
WO0028079A2 | Genetic variation associated with aplastic anemia, and diagnosis and therapy based thereon | |
WO0029614A1 | Human prostaglandin receptors and methods of use thereof | |
US6218524B1 | Genetic polymorphisms in the microsomal triglyceride transfer protein promoter and uses thereof |